IgniteData Expands EHR-to-EDC Capabilities with Yunu Integration for Imaging Data in Clinical Trials

WILMINGTON, Del., Feb. 3, 2025 /PRNewswire/ — IgniteData, a leader in EHR-to-EDC interoperability for clinical trials, has partnered with Yunu to enhance the seamless integration of imaging data into clinical trial workflows. This strategic collaboration enables pharmaceutical sponsors using IgniteData’s Archer EHR-to-EDC application to access audit-ready, radiologist-controlled imaging assessments directly within their EDC system, improving data accuracy, trial efficiency, and decision-making.

By incorporating Yunu-managed imaging workflows, IgniteData expands its capabilities to address a long-standing challenge in clinical trials: the lack of standardized, structured imaging data within EHR systems. While trial sites generate critical imaging assessments, these results are often delayed, error-prone, and lack the audit-readiness required for regulatory compliance. With Yunu’s industry-leading imaging platform now integrated with Archer, sponsors gain real-time access to structured imaging endpoints, ensuring greater accuracy, consistency, and efficiency across trials.

Key Benefits for IgniteData Customers

  • Enhanced Data Standardization: By integrating imaging data alongside EHR-sourced clinical data, IgniteData delivers a complete and accurate dataset within sponsors’ EDC systems, eliminating manual data reconciliation.
  • Optimized Workflow & Site Productivity: The combined solution automates imaging data capture, reducing administrative burden on trial sites and minimizing delays in data availability.
  • Faster, More Accurate Imaging Assessments: With Yunu ensuring radiologist-verified results, sponsors can confidently use imaging data for eligibility assessments, longitudinal tracking, and regulatory submissions.
  • Accelerated Trial Timelines & Reduced Error Rates: By streamlining imaging workflows and minimizing site-level dependencies, the integration reduces costly data errors and accelerates trial execution.
  • AI-Enabled Decision-Making: Sponsors can now apply AI-driven insights to imaging assessments directly within Archer, unlocking new opportunities for data-driven trial optimization.

“IgniteData is committed to redefining clinical trial data workflows by eliminating interoperability challenges and reducing manual data entry,” said Steve Tolle, Chief Product Officer at IgniteData. “Through our integration with Yunu, we are expanding Archer’s capabilities to include structured imaging results, offering sponsors a more complete and real-time view of all critical trial data. This partnership enhances data integrity, improves trial efficiency, and ultimately accelerates the path to regulatory success.”

Both IgniteData (Booth #841) and Yunu (Booth #106) will be exhibiting at SCOPE 2025, February 3-6 in Orlando, Florida, where sponsors and CROs can schedule a meeting to learn more about the new offering.

For more information, visit www.ignitedata.com and www.yunu.io.

About IgniteData 

IgniteData is transforming the future of clinical trials through Archer, its cloud-based EHR-to-EDC interoperability solution. Designed for seamless, secure data transfer between electronic health records and research applications, Archer streamlines trial workflows, reduces manual data entry, and ensures real-time access to critical study data. By enabling faster, more accurate clinical data exchange, IgniteData helps sponsors optimize trial timelines and enhance data integrity across global studies. Learn more at www.ignitedata.com.

About Yunu 

Yunu is the industry leader in clinical trial imaging workflows, providing cutting-edge technology to optimize imaging data capture, standardization, and compliance. Supporting over 5,000 active clinical trials, Yunu’s platform serves as the primary imaging data system for 25% of all NCI-designated Comprehensive Cancer Centers. By integrating with IgniteData’s Archer, Yunu ensures trial sponsors gain immediate, audit-ready imaging endpoint access within their EDC systems. For more information, visit www.yunu.io.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ignitedata-expands-ehr-to-edc-capabilities-with-yunu-integration-for-imaging-data-in-clinical-trials-302366028.html

SOURCE IgniteData

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

5 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

7 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

7 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

7 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

7 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

7 hours ago